Related Experiment Videos
The hereditary and acquired deficiencies of complement
Insights
Complement deficiencies impact immunity and autoimmune diseases. Recognizing these, like C1 inhibitor deficiency in angioedema or C3 deficiency in infections, is crucial for effective treatment.
Area of Science:
- Immunology
- Clinical Medicine
- Genetics
Background:
- The complement system is vital for immunity and its deficiencies link to various diseases.
- Understanding complement's role in pathogenesis is evolving.
- Clinical syndromes associated with complement deficiencies are increasingly recognized.
Purpose of the Study:
- To highlight key complement deficiencies and their associated clinical syndromes.
- To inform clinicians about the diagnostic and therapeutic implications of these deficiencies.
- To underscore the importance of complement analysis in patient management.
Main Methods:
- Review of clinical syndromes associated with hereditary and acquired complement deficiencies.
- Analysis of complement component deficiencies (C1 inhibitor, C3, C5-C8, C2, C4) and their clinical presentations.
- Correlation of specific deficiencies with allergic, infectious, and rheumatic diseases.
Main Results:
- C1 inhibitor deficiency presents as angioedema; diagnosis is key for effective therapy.
- Acquired C1q deficiency is linked to chronic urticaria and vasculitis.
- Deficiencies in C3, C5-C8 are associated with severe infections (bacterial, meningococcal, gonococcal).
- C2 and C4 deficiencies are linked to systemic lupus erythematosus (SLE), often with characteristic skin manifestations and autoantibodies.
Conclusions:
- Complement deficiencies are associated with distinct clinical syndromes impacting immunity and autoimmunity.
- Prompt diagnosis through complement analysis is critical for appropriate and effective treatment.
- Further research into complement's pathobiology will expand understanding of human disorders.
Abstract:
The identification of hereditary and acquired complement deficiencies in humans has led to a better understanding of the biologic importance of the complement system in immunity and autoimmune disease. Although the understanding of the relevance of complement in the pathogenesis of disease is incomplete, several characteristic clinical syndromes associated with complement deficiencies have been recognized and should be known to the practicing clinician. In allergic diseases, one need recognize the C1 inhibitor deficiency syndromes which can present as severe, recurrent angioedema in childhood or in the adult as recurrent angioedema in association with a lymphoid malignancy or autoimmune disease. Complement analyses allow one to readily diagnose C1 inhibitor deficiency in angioedema. Correct diagnosis is critical because safe effective therapy is available. Chronic urticaria is also uncommonly associated with complement deficiencies, particularly acquired C1q deficiency. Again, effective therapy for hypocomplementemic urticarial vasculitis and C1q deficiency is available and differs significantly from the usual management of chronic urticaria. Homozygous and acquired deficiencies of C3 are associated with severe immune deficiency and recurrent infections with gram-positive and gram-negative bacteria. Recurrent meningococcemia and gonococcemia are being identified frequently in patients with a deficient membrane attack mechanism relating to deficiency of C5, C6, C7, or C8. Nearly one third of the patients developing meningococcemia may have an associated complement deficiency indicating the importance of complement determinations in understanding the treatment and prognosis for these patients. Deficiency of almost every complement component has been reported in association with one or more rheumatic diseases, particularly systemic lupus erythematosus. Extensive studies of C2 deficiency and limited studies of C4 deficiency indicate that these components of the classical pathway of complement are important in preventing the development of SLE or are linked to other genes predisposing to SLE. The clinical presentations of SLE in association with C2 or C4 deficiency are relatively uniform. The patients exhibit typical skin manifestations suggestive of SLE and DLE and often exhibit antibodies to SSA (Ro). The association of complement deficiencies with clinical syndromes is important for today's physician. The syndromes and deficiencies described here are the beginning of an expanding knowledge relating to the pathobiology of complement in human disorders.